Oncogene expression in cholangiocarcinoma and in normal hepatic development.
about
Monoamine oxidase A expression is suppressed in human cholangiocarcinoma via coordinated epigenetic and IL-6-driven eventsTranscriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB.Cell proliferation and oncogene expression after bile duct ligation in the rat: evidence of a specific growth effect on bile duct cells.Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.Molecular mechanisms underlying hepatocellular carcinomaNEU overexpression in the furan rat model of cholangiocarcinogenesis compared with biliary ductal cell hyperplasia.Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses.Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinomaEGFR and HER2 expression in advanced biliary tract cancer.HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?High expression of ErbB2 contributes to cholangiocarcinoma cell invasion and proliferation through AKT/p70S6KLoss of constitutional heterozygosity on chromosomes 5 and 17 in cholangiocarcinoma.JQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of Cholangiocarcinoma.Binding of tumour necrosis factor-alpha (TNF-alpha) to TNF-RI induces caspase(s)-dependent apoptosis in human cholangiocarcinoma cell lines.
P2860
Q28273377-D278EAA3-876C-47A2-BE9D-8CD94CA760DCQ34070947-2647B120-BB02-42BD-8B5E-7680470AFBB0Q34237832-ADD70B98-2E2F-44A5-B33F-62BD4B13F14EQ34978321-FA0B07CD-5243-4B75-B904-66BF775D2234Q35260040-AC97FE8F-8D3D-4538-A535-6E8C975F5921Q35764997-42F15202-459D-4899-A8FE-DB71F3444263Q36694963-DB26693A-1AAE-4F45-8012-EAA4D836EAB6Q37351498-A2AF6973-B8A2-486E-9CC4-1C81E14C3BA4Q37362858-9B1C0119-25D0-470E-8A4D-7848B6124C5EQ39040859-547A4064-B644-4C91-A5F4-7BE383A780F9Q39664471-05023AB6-D790-4604-ABD4-7BCACE0CDC21Q42263314-C48BCDED-B9A8-4A78-9092-59F14A85518DQ47398665-DAF9938B-A83F-4E31-94CC-492D734412D8Q54099114-75A0DCC0-FD80-4E98-ADC9-237EEDB780B3
P2860
Oncogene expression in cholangiocarcinoma and in normal hepatic development.
description
1989 nî lūn-bûn
@nan
1989 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Oncogene expression in cholangiocarcinoma and in normal hepatic development.
@ast
Oncogene expression in cholangiocarcinoma and in normal hepatic development.
@en
Oncogene expression in cholangiocarcinoma and in normal hepatic development.
@nl
type
label
Oncogene expression in cholangiocarcinoma and in normal hepatic development.
@ast
Oncogene expression in cholangiocarcinoma and in normal hepatic development.
@en
Oncogene expression in cholangiocarcinoma and in normal hepatic development.
@nl
prefLabel
Oncogene expression in cholangiocarcinoma and in normal hepatic development.
@ast
Oncogene expression in cholangiocarcinoma and in normal hepatic development.
@en
Oncogene expression in cholangiocarcinoma and in normal hepatic development.
@nl
P2093
P1433
P1476
Oncogene expression in cholangiocarcinoma and in normal hepatic development.
@en
P2093
P304
P407
P577
1989-12-01T00:00:00Z